Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

January 26, 2023

Conditions
Malaria,Falciparum
Interventions
DRUG

Artesunate-amodiaquine combination

Tablets containing 50mg/135 mg or 100mg/270 mg of artesunate/amodiaquine will be administered according to weight as per manufacturer guidelines

DRUG

Primaquine Phosphate

The single dose of 0.25mg/kg PQ will be administered in an aqueous solution, according to a standard operating procedure (SOP) provided by the manufacturer.

DRUG

Artemether-lumefantrine

Tablets containing 20 mg artemether and 120 mg lumefantrine will be administered according to weight as per manufacturer guidelines

DRUG

Amodiaquine

Tablets containing 153 mg of amodiaquine will be administered according to weight, aiming for a dosage of approximately 10 mg (7.7-15.3mg)/kg/day, given once or twice daily (together with artemether-lumefantrine) for three days.

Trial Locations (1)

Unknown

Malaria Research and Training Centre, Bamako

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER